Physician profile
Hannah Evans
NPI 1275154536
$4,071.91
in general payments reported to CMS, 2019-2025
25 companies · $30.02 in 2025
The $30.02 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,945 · 2022: $1,732 · 2023: $272 · 2024: $92.01 · 2025: $30.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,042.00 | 2021-2023 | Tezspire, Fasenra, Symbicort |
| Glaxosmithkline, LLC. | $408.23 | 2021-2023 | Nucala, Trelegy Ellipta |
| Regeneron Healthcare Solutions, INC. | $401.70 | 2021-2023 | Dupixent |
| Mylan Specialty L.P. | $308.53 | 2021-2022 | |
| Genzyme Corporation | $279.86 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $239.70 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $200.81 | 2021-2024 | Acthar |
| United Therapeutics Corporation | $176.71 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $164.65 | 2021 | |
| Astellas Pharma US INC | $116.62 | 2021 | |
| Philips North America LLC | $114.95 | 2021-2025 | Vest Therapy Und |
| Insmed, INC. | $107.15 | 2021 | |
| Amgen INC. | $96.53 | 2021-2022 | |
| Baxter Healthcare | $70.16 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| Inogen, INC. | $53.71 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $46.10 | 2021 | |
| Grifols USA, LLC | $43.53 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $41.60 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.50 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $28.93 | 2021-2022 | |
| Pulmonx Corporation | $26.08 | 2024 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Medtronic, INC. | $22.40 | 2023 | Percept PC Brainsense |
| Sanofi-Aventis U.S. LLC | $19.41 | 2021 | |
| Vanda Pharmaceuticals INC. | $14.81 | 2025 | Ponvory |
| Sunovion Pharmaceuticals INC. | $13.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.